BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND PBRM1, BAF180, 55193, PB1, MGC156156, MGC156155
6 results:

  • 1. Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma.
    Ackroyd SA; Arguello D; Ramos P; Mahdi H; ElNaggar A; Winer I; Holloway R; Krivak T; Jones N; Turner VG; Herzog T; Chu C; Brown J; Mantia-Smaldone G
    Gynecol Oncol; 2023 Feb; 169():164-171. PubMed ID: 36333181
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. PTEN Loss and ARID1A Mutation in an HPV-positive Metastatic Adenocarcinoma Diagnosed Almost 18 yr After an Intact Cone Excision for Endocervical Adenocarcinoma In Situ.
    Aisagbonhi O; Zare SY; Hasteh F; Binder P; Roma AA; Fadare O
    Int J Gynecol Pathol; 2022 May; 41(3):307-312. PubMed ID: 34282106
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Pathological and molecular features of malignancies underlined by BAF complexes inactivation].
    Le Quang M; Ranchère-Vince D; Le Loarer F
    Ann Pathol; 2019 Dec; 39(6):399-413. PubMed ID: 31255411
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells.
    Enane FO; Saunthararajah Y; Korc M
    Cell Death Dis; 2018 Sep; 9(9):912. PubMed ID: 30190481
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Targeting chromatin defects in selected solid tumors based on oncogene addiction, synthetic lethality and epigenetic antagonism.
    Morel D; Almouzni G; Soria JC; Postel-Vinay S
    Ann Oncol; 2017 Feb; 28(2):254-269. PubMed ID: 28426098
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies.
    Decristofaro MF; Betz BL; Rorie CJ; Reisman DN; Wang W; Weissman BE
    J Cell Physiol; 2001 Jan; 186(1):136-45. PubMed ID: 11147808
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.